Acomplia (rimonabant)
Although it's been much talked about lately, Acomplia, the so-called weight-loss
magic pill has not yet been approved for use in the United States. Acomplia is
poised to become one of the pharmaceutical industry's blockbusters - not only
have initial test results gone remarkably well, and additionally, it seems Acomplia
will be serve a dual purpose of fighting obesity and helping smokers to quit.
Acomplia's manufacturers (Sanofi) plan to file for regulatory approval early next
year (2005) in the United States and Europe.
Many dream of the day that they could really lose weight just by taking a pill.
With Acomplia having impressive initial results, that dream may be a reality very
soon. Based on studies over two years, users lost an average of 19 pounds and
actually kept the weight off. Users also appeared to suffer fewer serious side
effects than users of existing diet drugs such as Meridia
and Xenical.
These results were recently announced at a meeting of the American Heart Association
in New Orleans. The study included 3,040 obese people who were randomly assigned
to take two different doses of Acomplia or an inactive placebo. They were all
prescribed a moderate diet that, if followed, would cut 600 calories per day.
Among the higher-dose Acomplia users, levels of good HDL cholesterol increased
25%, while bad triglycerides dropped 10%.
Additionally, there was an impressive decrease in fat around the belly of users,
an indicator which may be a better measure of heart disease risk than overall
weight. An earlier study found that 44 percent of American adults have waistlines
greater than the risk threshold of 40 inches in men and 35 inches in women. In
the higher-dose Acomplia group, waistlines shrank an average of 3.1 inches.
The placebo survey group lost an average of 5 lbs (14 lbs less than the average
for those taking the higher dose of Acomplia). 63% percent of the higher-dose
Acomplia users lost at least 5% of their body weight, while 33% lost at least
10%.
Top top it off, clinical trials in the United States indicated that Acomplia,
taken in daily 20 milligram doses, can nearly double a patient's odds of stopping
smoking. A study of 787 smokers who smoked an average of 23 cigarettes a day found
that 36% of those who took Acomplia once a day actually quit smoking. By comparison,
only 21 percent who took a placebo quit successfully. Acomplia also prevented
the weight gain that many smokers experience after quitting. Acomplia users lost,
on average, just over half a pound, while smokers who took a placebo while trying
to quit gained 2.5 pounds.
Acomplia is quite promising weight loss drug and Prescriptions1.Net will provide
more details and follow-ups as development and FDA-approval proceed.
Specific Acomplia articles and press releases
An
effective obesity drug
Diet
pill a driving force
Copyright ©
2017 Prescriptions1.Net | All rights reserved | Online
Pharmacy Affiliate Programs | Privacy
 |
Featured Prescriptions
Dental Health: An estimated 156 million Americans have dental coverage.
 Prescription1.Net
takes a closer look at Dental Health Plans
as well as other important dental health topics. If you are in search
of a good dental health plan, click the link above as we look at the ins
and outs of getting dental health insurance.
Other Sections: Mental Health, Integrative
Health, Psoriasis
Important Note / Disclaimer:
The information here at Prescriptions1.Net is intended to supplement,
not be a substitute for the expertise and judgment of a doctor, pharmacist
or other healthcare professional. It should not be construed to indicate
that use of any of the prescription drugs featured here is safe, appropriate,
or effective for everyone. Consult a healthcare professional before you
use any of these drugs. See prescription pictures here. |
|
